Dupuytren’s contracture is progressive thickening of the palmar fascia that pulls fingers — usually the ring and little fingers — into permanent flexion. It is about 1.6 times more common in people with diabetes, often more bilateral and less severe than the non-diabetic form. Diagnosis is clinical, with the table-top test marking the threshold for treatment. Options include observation, needle aponeurotomy, collagenase injection (Xiaflex), and open fasciectomy — with recurrence common across all approaches.
What Dupuytren’s Contracture Is
The palmar fascia is a sheet of tough connective tissue that anchors the skin of the palm to the underlying bone and tendons. In Dupuytren disease, abnormal fibroblasts called myofibroblasts proliferate within the fascia and form nodules, then cords. The cords contract along the line of the digital tendons, slowly pulling the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints into flexion. The ring and little fingers are most affected, the middle finger less so, and the index and thumb less still. The disease can affect the foot (Ledderhose disease) and penis (Peyronie disease) by the same biology.
Dupuytren is most common in people of Northern European descent — “Viking disease” — but occurs worldwide. In diabetic populations the prevalence is higher and the disease often presents differently.
Why It Is More Common in Diabetes
- Increased collagen cross-linking from advanced glycation end-products (AGEs)
- Up-regulation of TGF-beta and pro-fibrotic cytokines
- Microvascular changes promoting myofibroblast activity
- Long-duration diabetes is the strongest risk factor
- Both type 1 and type 2 diabetes raise risk
- Higher A1C correlates with greater prevalence
Diabetic Versus Non-Diabetic Dupuytren
| Feature | Diabetic Dupuytren | Classic Northern European |
|---|---|---|
| Severity | Often milder | Frequently more severe |
| Bilaterality | More commonly bilateral | Often unilateral first |
| Fingers affected | Middle and ring more common | Ring and little more typical |
| Progression | Slower | Faster, especially with diathesis |
| Family history | Less prominent | Strong genetic clustering |
| Coexisting conditions | Frozen shoulder, trigger finger, carpal tunnel | Often isolated to hand |
Risk Factors
- Diabetes (type 1 or type 2)
- Older age — typically 50 plus
- Male sex (3 to 4 times more common, gap narrows with age)
- Northern European ancestry
- Family history
- Alcohol use
- Smoking
- Manual work and previous hand trauma (debated)
- Epilepsy and anticonvulsant use (older literature)
Symptoms and Stages
- Painless nodules in the palm near the base of the ring or little finger
- Skin pits or dimples over the nodules
- Palpable cords extending from palm toward the finger
- Gradual MCP joint flexion contracture
- Later PIP joint involvement
- Difficulty washing the face, shaking hands, wearing gloves
- Functional impact often progressive over years
Diagnosis
Clinical Examination
- Inspect palm for nodules, pits, and cords
- Palpate to distinguish skin-tethered cords from tendons
- Measure MCP and PIP joint contractures with goniometer
- Table-top test (Hueston) — patient places palm flat; inability to flatten is positive
- Document any Garrod nodules over PIP joint dorsum (diathesis sign)
- Check for Ledderhose plantar nodules and Peyronie
Imaging
- Usually not needed
- Ultrasound rarely used for diagnostic clarification
- MRI almost never indicated
Differential Diagnosis
- Stenosing tenosynovitis (trigger finger)
- Camptodactyly
- Ulnar nerve palsy with intrinsic minus posture
- Diabetic stiff hand syndrome / cheiroarthropathy
- Tendon nodule
- Inclusion cyst
Treatment
Observation
- Most early disease without functional impact
- Stretching exercises and patient education
- Monitor for progression every 6 to 12 months
Percutaneous Needle Aponeurotomy
- In-office procedure under local anesthesia
- Needle used to weaken cord, then manual extension breaks it
- Rapid recovery, modest cost
- Best for MCP contractures and cord-dominant disease
- Higher recurrence than open surgery
Collagenase Clostridium Histolyticum (Xiaflex)
- Enzyme injected into cord; manipulation 24 to 72 hours later
- Office-based
- FDA-approved for MCP and PIP contractures
- Recurrence rates similar to needle aponeurotomy
- Skin tears and bruising common
Open Fasciectomy
- Surgical removal of diseased fascia
- Best for severe, recurrent, or PIP-dominant disease
- Longer recovery (weeks to months)
- Hand therapy after surgery is essential
- Lowest recurrence rates
Dermofasciectomy
- Removal of involved skin and fascia, with skin graft
- Reserved for very aggressive or recurrent disease
- Lower recurrence rate within grafted area
Radiation Therapy
- Low-dose external beam in early nodular disease
- Aims to halt progression rather than reverse established contracture
- European centers more familiar with use
Comparing Outcomes
| Treatment | Recurrence at 5 Years | Recovery Time | Best For |
|---|---|---|---|
| Needle aponeurotomy | About 50 percent | Days | MCP contractures, mild-moderate |
| Collagenase injection | About 50 percent | 1 to 2 weeks | MCP and some PIP |
| Open fasciectomy | 15 to 30 percent | 6 to 12 weeks | Severe, recurrent, or PIP-dominant |
| Dermofasciectomy | Lowest | 8 to 12 weeks | Aggressive disease, skin involvement |
Coexisting Hand Conditions in Diabetes
| Condition | Description | Prevalence in Diabetes |
|---|---|---|
| Stiff hand syndrome (cheiroarthropathy) | Limited joint mobility, prayer sign positive | 30 to 50 percent in long-duration T1D |
| Trigger finger | Stenosing flexor tenosynovitis | 5 to 10 percent vs 2 percent general |
| Carpal tunnel syndrome | Median nerve compression at wrist | 14 to 30 percent |
| Frozen shoulder | Adhesive capsulitis | 10 to 20 percent |
Glycemic Control and Procedure Planning
- Optimize A1C before elective surgery — see our A1C levels guide
- Watch for delayed wound healing
- Consider infection risk in immunocompromised states
- Continue hand therapy regardless of intervention type
Prevention and Long-Term Management
- Tight glycemic control may slow progression
- Daily hand stretching
- Avoid prolonged repetitive trauma where possible
- Address coexisting hand and shoulder issues such as frozen shoulder
- Smoking and heavy alcohol reduction
- Regular hand exam during annual diabetes review — see our complications and related conditions hub for the wider picture
The Bottom Line
Dupuytren’s contracture is progressive thickening of the palmar fascia causing finger flexion deformity, and is more common in people with diabetes. Diabetic Dupuytren tends to be milder, more bilateral, and slower than the classic Northern European form, though disabling cases still occur. Diagnosis is clinical, with the table-top test marking the threshold for intervention. Mild disease is observed; moderate disease is treated with needle aponeurotomy or collagenase injection; severe or recurrent disease is treated with open fasciectomy. Recurrence is common across treatments, so realistic expectations matter. Talk to your doctor at the first sign of palm nodules or finger stiffness, especially if it interferes with daily tasks.
